0001181431-13-028130.txt : 20130516
0001181431-13-028130.hdr.sgml : 20130516
20130516071822
ACCESSION NUMBER: 0001181431-13-028130
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130515
FILED AS OF DATE: 20130516
DATE AS OF CHANGE: 20130516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH MARK L
CENTRAL INDEX KEY: 0001206467
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35073
FILM NUMBER: 13849464
MAIL ADDRESS:
STREET 1: NABI PHARMACEUTICALS
STREET 2: 5800 PARK OF COMMERCE BLVD N.W.
CITY: BOCA RATON
STATE: FL
ZIP: 33487
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gevo, Inc.
CENTRAL INDEX KEY: 0001392380
STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860]
IRS NUMBER: 870747704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: 303-858-8358
MAIL ADDRESS:
STREET 1: 345 INVERNESS DRIVE SOUTH, BUILDING C
STREET 2: Suite 310
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: Gevo Inc
DATE OF NAME CHANGE: 20070307
4
1
rrd380099.xml
SHARES SOLD UNDER 10B5-1 PLAN
X0306
4
2013-05-15
0
0001392380
Gevo, Inc.
GEVO
0001206467
SMITH MARK L
GEVO, INC.,345 INVERNESS DRIVE SOUTH
BUILDING C, SUITE 310
ENGLEWOOD
CO
80112
0
1
0
0
Chief Financial Officer
Common Stock
2013-05-15
4
S
0
351
1.62
D
178910
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading adopted December 14, 2012. The shares sold represent shares of restricted stock granted to the reporting person that have recently vested. Such shares were sold to satisfy certain tax obligations of the reporting person triggered by the vesting of such shares.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.67, inclusive. The reporting person undertakes to provide to Gevo, Inc., any security holder of Gevo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
/s/ Brett Lund, Attorney-in-Fact
2013-05-16